fulvestrant has been researched along with leucine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mellor, SJ; Thomas, EJ | 1 |
| Abrams, J; Deighton-Collins, S; Koide, A; Koide, S; Martinez, A; Schwartz, JA; Skafar, DF; Zhao, C | 1 |
| Auger, A; Cotnoir-White, D; Dayan, G; Hébert, E; Hilmi, K; Jeyakumar, M; Katzenellenbogen, J; Loch, C; Lupien, M; Mader, S; Moras, D; Pinard, GA; Wurtz, JM | 1 |
3 other study(ies) available for fulvestrant and leucine
| Article | Year |
|---|---|
Interactions between oestradiol and epidermal growth factor in endometrial stromal proliferation and differentiation.
Topics: Blotting, Western; Cell Differentiation; Cell Division; Cells, Cultured; Endometrium; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Leucine; Receptors, Estrogen; Thymidine | 1995 |
Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
Topics: Amino Acid Substitution; Base Sequence; Binding Sites; DNA; Estradiol; Estrogen Receptor alpha; Fulvestrant; HeLa Cells; Humans; In Vitro Techniques; Leucine; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Protein Conformation; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Transcription Factor AP-1; Transcriptional Activation; Two-Hybrid System Techniques | 2003 |
Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.
Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Cell Nucleus; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Humans; Leucine; Molecular Sequence Data; Mutation; Protein Structure, Secondary; Raloxifene Hydrochloride; Solubility; Transcription, Genetic; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2007 |